Popular Articles From: UPDATE: Why the Dow's 2014 gain is kind of meh to 2014 San Antonio Breast Cancer Symposium to Feature Oncotype DX® DCIS Study in Press Program on Friday, December 12


By Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- The Dow Jones Industrial Average's gain of 7.5% in 2014 is actually just "meh." The blue-chip gauge's(DJI) average yearly move in the last couple of decades is a 9.7% jump, according to FactSet data going back to 1988.
Sign-up for UPDATE: Why the Dow's 2014 gain is kind of meh investment picks
2014/12/31
By Victor Reklaitis and Sara Sjolin, MarketWatch NEW YORK (MarketWatch)--U.S. stocks turned moderately negative in afternoon action Wednesday, yet remained on track for solid yearly gains with just a few hours of trading left in 2014.
Sign-up for MARKET SNAPSHOT: Dow Struggles Near 18,000, Stays On Track For Solid Yearly Gain investment picks
http://media.marketwire.com/attachments/201104/61410_qualitystocks-300dpi.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159038&ProfileId=051205&sourceType=1 SCOTTSDALE, AZ --
Sign-up for IFAN Financial, Inc. (IFAN) Announces Engagement of QualityStocks Investor Relations Services investment picks
2015/1/1
Millions of votes cast in the national, fan-driven competition MCLEAN, Va.
Sign-up for Auburn's Aubie the Tiger Roars to Victory in the 2014 Capital One Mascot Challenge investment picks
In Voting Overwhelmingly on Broadfin's Gold Proxy Card Shareholders Followed the Recommendations of ISS and Glass Lewis Broadfin Looks Forward to a Refreshed Board with Five Recent Additions and the Opportunity to Create Immediate Positive Impact NEW YORK , Dec.
Sign-up for Broadfin Capital Thanks Shareholders For Their Overwhelming Support In Electing Its Three Director Candidates To The Board Of Directors Of Cardica investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- With gas prices at multiyear lows and consumer sentiment at multiyear highs, retail sales data will likely be the main catalyst for stocks this week.
Sign-up for UPDATE: Retail sales data to confirm tone of holiday shopping investment picks
By Wallace Witkowski and Sue Chang, MarketWatch Shares continue advancing after hours on Halliburton interest SAN FRANCISCO (MarketWatch) -- Baker Hughes Inc. shares continued rising after hours Thursday following a surge in the regular session on news of a possible buyout.
Sign-up for UPDATE: Baker Hughes shares rise on possible buyout investment picks
2014/11/4
By Jeff Reeves, MarketWatch Crude oil prices are hovering around $80 a barrel, the lowest level since summer 2012.
Sign-up for UPDATE: Now's your chance to buy these cheap oil stocks investment picks
Pfizer Inc. (NYSE:PFE) announced today the publication of results from the PROFILE 1014 study in the December 4 issue of The New England Journal of Medicine .
Sign-up for Phase 3 Results Published in The New England Journal of Medicine Show Superiority of Pfizer’s XALKORI® (crizotinib) Compared to Platinum-Based Chemotherapy in Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer investment picks
Pfizer Inc. (NYSE:PFE) today announced the publication of the detailed results from PALOMA-1, a randomized Phase 2 study of palbociclib in combination with letrozole versus letrozole alone, in The Lancet Oncology .
Sign-up for Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology investment picks
CANONSBURG, Pa.
Sign-up for Rice Energy Reports Third Quarter 2014 Results investment picks
2015/1/9
By Yvonne Lee And Chester Yung HONG KONG--Asia's richest man, Li Ka-shing, is reorganizing his empire into two companies, separating his Hong Kong property assets from his internationally focused ports-to-telecom conglomerate.
Sign-up for Li Ka-shing to Divide Empire -- 2nd Update investment picks
2014/12/12
By Mitch Rothschild Better medical choices and outcomes benefit patients A tidal wave of innovation is going to affect health care.
Sign-up for UPDATE: 5 health-care sector prescriptions for 2015 investment picks
2014/10/29
With only 49 percent of Americans invested in the stock market 1 , down from 65 percent in 2007 2 , many Americans today feel cash is king.
Sign-up for TD Ameritrade's Advisory Affiliate, Amerivest®, Launches First-of-its-Kind Rebate Offer investment picks
Landmark Study Reconfirms Oncotype DX® Stratifies DCIS Patient Risk Additional Presentations Include Positive Results from Genomic Health's First Liquid Biopsy Study in Breast Cancer REDWOOD CITY, Calif.
Sign-up for 2014 San Antonio Breast Cancer Symposium to Feature Oncotype DX® DCIS Study in Press Program on Friday, December 12 investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Popular Articles From: UPDATE: Why the Dow's 2014 gain is kind of meh to 2014 San Antonio Breast Cancer Symposium to Feature Oncotype DX® DCIS Study in Press Program on Friday, December 12
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent